Locate family members with the last name MASEREEUW.

There is no place like 127.0.0.1
 ©

R Masereeuw is an academic who published a paper in 2015 entitled Pharmacokinetics, safety and tolerability of human recombinant alkaline phosphatase in healthy volunteers. The paper was published in a journal entitled Critical Care.

R. Masereeuw is an academic who published a paper in 2017-09-06 entitled Mild intracellular acidification by dexamethasone attenuates mitochondrial dysfunction in a human inflammatory proximal tubule epithelial cell model. The paper was published in a journal entitled Scientific Reports.

Roos Masereeuw is an academic who published a paper in 2019-03-14 entitled Serum levels of miR-126 and miR-223 and outcomes in chronic kidney disease patients. The paper was published in a journal entitled Scientific Reports.

Rosalinde Masereeuw is an academic who published a paper in 2020-08-28 entitled Fabrication of Kidney Proximal Tubule Grafts Using Biofunctionalized Electrospun Polymer Scaffolds. The paper was published in a journal entitled Macromolecular bioscience.

ROSALINDE MASEREEUW is an academic who published a paper in 2021 entitled Association between Genetic Variants and Cisplatin-Induced Nephrotoxicity: A Genome-Wide Approach an. ROSALINDE MASEREEUW published this work as part of a team: Zazuli, Zulfan. Here is a description of this work: This study aims to evaluate genetic risk factors for cisplatin-induced nephrotoxicity by investigating not previously studied genetic risk variants and further examining previously reported genetic associations. A genome-wide study (GWAS) was conducted in genetically estimated Europeans in a discovery cohort of cisplatin-treated adults from Toronto, Canada, followed by a candidate gene approach in a validation cohort from the Netherlands. In addition, previously reported genetic associations were further examined in both the discovery and validation cohorts. The outcome, nephrotoxicity, was assessed in two ways: (i) decreased estimated glomerular filtration rate (eGFR), calculated using the Chronic Kidney Disease Epidemiology Collaboration formula (CKD-EPI) and (ii) increased serum creatinine according to the Co.

ROSALINDE MASEREEUW is an academic.